Mobile Menu Toggle

ABLAZE SPOTLIGHT ON SCIENCE FICTION SET (MR)

ABLAZE PUBLISHING
MAY240944
(W) Various (A) Various (CA) VARIOUS
 ABLAZE is shining the spotlight on the wide variety of genres and fantastic works within our catalogue! Our Spotlight on Science Fiction includes three comic titles - Life Zero, Promethee 13:13, and Children of the Black Sun Vol. 1 - bundled together under a specially discounted price.

In Life Zero: As a mysterious cloud passes through the world's population centers, people die...then they return to life as shambling, ravenous monsters. When a team is sent into the fray to break Captain Derek Shako from prison, they soon discover that he has his own agenda that takes precedence over any other grand schemes. The completion of any mission, however, requires escape from the beleaguered, infected city...

In Promethee 13:13: Darla Clemenceau has been plagued by apocalyptic visions ever since she was abducted by a UFO as a child. Now, she's ready to put it all behind her and move on with her life. But what if it's all true? A dangerous cult militia is prepping for the end of the world, and they see Darla as the key to their survival...

In Children of the Black Sun: Over the years, a black sun has risen twice, dark dawn whose rays have done terrible things to people's minds, driving them to all sorts of horror. Twelve years have passed since the last time, and the world still fears the return of that inexplicable phenomenon. But fear is not the only legacy of those terrible days. All the women who got pregnant under the influence of the black sun have given birth to babies with some... peculiarities. White hair, ashy skin, abnormal proportions, and eyes as red as fire: the Children of the Black Sun.
In Shops: Jul 24, 2024
SRP: $48.00
Follow Us Facebook Icon Twitter Icon Instagram Icon YouTube Icon Rss Feed Email
Search for a Comic Shop

Cookies
We use cookies to understand how you use our site and to improve your experience. To manage our use of cookies click Cookie Policy.
By clicking 'Accept & Continue' or closing this banner, you accept our use of cookies.
}